The association between smoking and the development of rheumatoid arthritis: A population-based case-control study par Sánchez-Campamà, J, Nagra, NS, Pineda-Moncusí, M, Prats Uribe, A, Prieto Alhambra, D

“…The effect seems to prevail in the long-term and even in ex-smokers for 2 or more years after smoking cessation. More research is needed on the effects of smoking discontinuation on RA prevention and related outcomes.…”

Information sheets for patients with acute chest pain: randomised controlled trial par Arnold, J, Goodacre, S, Bath, P, Price, J

“…Main outcome measures: The primary outcome was anxiety (hospital anxiety and depression scale), health related quality of life (SF-36), patient satisfaction, presentation with further chest pain within one month, lifestyle change (smoking cessation, diet, exercise), further information sought from other sources, and planned healthcare seeking behaviour in response to further pain. …”

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. par Siva, R, Bafadhel, M, Monteiro, W, Brightling, C, Pavord, I

“…RATIONALE: Airway inflammation persists after smoking cessation in established chronic obstructive pulmonary disease (COPD), suggesting that other factors drive the airway inflammatory response. …”

Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. par Parkes, G, Greenhalgh, T, Griffin, M, Dent, R

“…Both groups were advised to quit and offered referral to local NHS smoking cessation services. MAIN OUTCOME MEASURES: The primary outcome measure was verified cessation of smoking by salivary cotinine testing 12 months after recruitment. …”

Reducing Smoking in Adolescents: Cost-Effectiveness Results From the Cluster Randomized ASSIST (A Stop Smoking In Schools Trial) par Hollingworth, W, Cohen, D, Hawkins, J, Hughes, R, Moore, L, Holliday, J, Audrey, S, Starkey, F, Campbell, R

“…The intervention is cost-effective under realistic assumptions regarding the extent to which reductions in adolescent smoking lead to lower smoking prevalence and/or earlier smoking cessation in adulthood. The annual cost of extending the intervention to Year 8 students in all U.K. schools would be in the region of £38 million and could result in 20,400 fewer adolescent smokers.…”

Information sheets for patients with acute chest pain: randomised controlled trial. par Arnold, J, Goodacre, S, Bath, P, Price, J

“…Secondary outcomes were depression (hospital anxiety and depression scale), health related quality of life (SF-36), patient satisfaction, presentation with further chest pain within one month, lifestyle change (smoking cessation, diet, exercise), further information sought from other sources, and planned healthcare seeking behaviour in response to further pain. …”

Lack of attentional retraining effects in cigarette smokers attempting cessation: a proof of concept double-blind randomised controlled trial. par Begh, R, Munafò, M, Shiffman, S, Ferguson, S, Nichols, L, Mohammed, M, Holder, R, Sutton, S, Aveyard, P

“…METHODS: This was a double-blind randomised controlled trial that took place in UK smoking cessation clinics. Smokers interested in quitting were randomised to five weekly sessions of attentional retraining (N=60) or placebo training (N = 58) using a modified visual probe task from one week prior to quit day. …”

A systematic review and meta-analysis of interventions to induce attempts to quit tobacco among adults not ready to quit par Klemperer, EM, Streck, JM, Lindson, N, West, JC, Su, A, Hughes, JR, Carpenter, MJ

“…The prevalence of past-year smoking cessation remains below 10% in the U.S. Most who smoke are not ready to quit in the near future. …”

Updating a systematic review--what difference did it make? Case study of nicotine replacement therapy. par Stead, L, Lancaster, T, Silagy, C

“…METHODS: We examined the effects of regular updating of a systematic review of nicotine replacement therapy for smoking cessation. We considered two outcomes. First, we assessed the effect of adding new data to meta-analyses, comparing results in 2000 with the results in 1994. …”

Lack of attentional retraining effects in cigarette smokers attempting cessation: A proof of concept double-blind randomised controlled trial par Begh, R, Munafò, MR, Shiffman, S, Ferguson, S, Nichols, L, Mohammed, M, Holder, R, Sutton, S, Aveyard, P

“…Methods: This was a double-blind randomised controlled trial that took place in UK smoking cessation clinics. Smokers interested in quitting were randomised to five weekly sessions of attentional retraining (N= 60) or placebo training (N= 58) using a modified visual probe task from one week prior to quit day. …”

Spontaneous very preterm birth in relation to social class, and smoking: a temporal-spatial analysis of routinely collected data in Aberdeen, Scotland (1985–2010) par McCall, SJ, Green, DR, Macfarlane, GJ, Bhattacharya, S

“…</br> <br><strong>Conclusion: </strong>The strongest risk factor for vPTB was maternal smoking while socioeconomic deprivation showed a strong association in non-smokers. Smoking cessation interventions may reduce vPTB. Modifiable risk factors should be explored in deprived areas.…”

Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. par Agudo, A, Ahrens, W, Benhamou, E, Benhamou, S, Boffetta, P, Darby, S, Forastiere, F, Fortes, C, Gaborieau, V, González, C, Jöckel, K, Kreuzer, M, Merletti, F, Pohlabeln, H, Richiardi, L, Whitley, E, Wichmann, H, Zambon, P, Simonato, L

“…After 10 years of smoking cessation, the relative risk decreased to 20% compared to current smokers. …”

Acceptability of financial incentives for health behaviours: A discrete choice experiment par Giles, E, Becker, F, Ternent, L, Sniehotta, F, McColl, E, Adams, J

“…Preferences were examined for financial incentives for: smoking cessation, regular physical activity, attendance for vaccination, and attendance for screening. …”

The Genetic Landscape of Renal Complications in Type 1 Diabetes par Sandholm, N, van Zuydam, N, Ahlqvist, E, Rayner, N, Juliusdottir, T, McCarthy, M, SUMMIT Consortium

“…We also found genome-wide genetic correlation between diabetic kidney disease and failure at smoking cessation (p=1.1×10-4 13 ). Pathway analysis implicated ascorbate and aldarate metabolism (p=9×10-6), and pentose and glucuronate interconversions (p=3×10-6 14 ) in pathogenesis of diabetic kidney disease. …”

A systematic review of interventions for smokers who contact quitlines. par Stead, L, Perera, R, Lancaster, T

“…DATA SOURCES: This review includes quitline studies identified as part of Cochrane reviews of telephone counselling and self help materials for smoking cessation. We updated the searches for this review. …”

Tobacco use and attitudes towards tobacco control activities of Malaysian dental students par Mohd Nor, Nor Azlida, Ismail, Nurulain, Ibrahim, Farhan, Razak, Ishak Abdul, Ab-Murat, Norintan

“…USIM students were significantly less likely to recall having received training about approaches to smoking cessation (52.9%, p < 0.001). Significantly fewer smokers than non-smokers agreed on tobacco banning policy. …”

Risk factors for early TB treatment interruption among newly diagnosed patients in Malaysia par Suliman, Qudsiah, Lim, Poh Ying, Md. Said, Salmiah, Tan, Kit-Aun, Mohd. Zulkefli, Nor Afiah

“…Efforts to quit smoking cessation programs and to promote stigma reduction interventions are crucial to reduce the probability of early treatment interruption.…”

The correlation of two nicotine dependence measurement methods: Fagerstrom Test for Nicotine Dependence (FTND) and saliva cotinine among a group of Muslim smoker in Malaysia par Zulkifley, Nuraisyah Hani, Ismail, Suriani, Abdul Manaf, Rosliza, Hamid, Zulkifley

“…Introduction: One of the known factors that hindered smoking cessation is nicotine dependence. Measurement of the nicotine dependence is important to better understand cigarette smoking addiction dependence and ways to overcome it. …”
Accéder au texte intégral

Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. par Roura, E, Castellsagué, X, Pawlita, M, Travier, N, Waterboer, T, Margall, N, Bosch, F, de Sanjosé, S, Dillner, J, Gram, I, Tjønneland, A, Munk, C, Pala, V, Palli, D, Khaw, K, Barnabas, R, Overvad, K, Clavel-Chapelon, F, Boutron-Ruault, M, Fagherazzi, G, Kaaks, R, Lukanova, A, Steffen, A, Trichopoulou, A, Trichopoulos, D

“…The strong beneficial effect of quitting smoking is an important finding that will further support public health policies for smoking cessation.…”

Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019 par Safiri, S, Nejadghaderi, SA, Abdollahi, M, Carson-Chahhoud, K, Kaufman, JS, Bragazzi, NL, Moradi-Lakeh, M, Mansournia, MA, Sullman, MJM, Almasi-Hashiani, A, Collins, GS, Kolahi, A

“…<br><strong> Conclusions<br></strong> The results of this study clearly illustrate that renewed efforts are required to increase utilization of evidence-based smoking cessation support in order to reduce the burden of smoking-related diseases.…”